China Universal Asset Management Co., Ltd. Kymera Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,733 shares of KYMR stock, worth $465,136. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,733
Previous 12,422
10.55%
Holding current value
$465,136
Previous $587,000
5.96%
% of portfolio
0.05%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.6MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$233 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$203 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$180 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$175 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$174 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.85B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...